| Gene symbol | TNFRSF17 | Synonyms | BCM, BCMA, CD269, TNFRSF13A | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p13.13 | dbXrefs | |
| Description | TNF receptor superfamily member 17 | ||||
| GTO ID | GTC2756 |
| Trial ID | NCT05008536 |
| Disease | Multiple Myeloma |
| Altered gene | BCMA |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | BCMA CAR-NK cells |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | Anti-BCMA CAR-NK Cell Therapy for the Relapsed or Refractory Multiple Myeloma |
| Year | 2021 |
| Country | China |
| Company sponsor | Xinqiao Hospital of Chongqing |
| Other ID(s) | BCMA NK for MM |
| Cohort 1 | |||||||||||
|
|||||||||||